Clinical Trial Detail

NCT ID NCT03605589
Title Pembro + Blina Combination in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Leukemia or Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Children's Hospital Medical Center, Cincinnati
Indications

B-cell lymphoma

childhood B-cell acute lymphoblastic leukemia

Therapies

Blinatumomab + Pembrolizumab

Age Groups: adult child

No variant requirements are available.